Deoferio v. Intel Technology
REITERATIONFacts
The Antecedents: Marlo A. Deoferio was employed by Intel Technology Philippines, Inc. (Intel) as a product quality and reliability engineer in 1996. In 2001, he was assigned to the United States as a validation engineer. During this assignment, he was repatriated to the Philippines in January 2002 after being hospitalized for major depression with psychosis. Following his return, he continued to work for Intel as a product engineer, but underwent extensive medical and psychiatric treatment at Intel's expense. Diagnoses from various medical professionals indicated mood disorder, major depression, auditory hallucination, and eventually schizophrenia. Dr. Paul Lee, a consultant psychiatrist, concluded in January 2006 that Deoferio's psychotic symptoms were not curable within six months and would negatively affect his work and social relations. Based on these findings, Intel issued Deoferio a notice of termination on March 10, 2006. Procedural History: Deoferio filed a complaint for illegal dismissal and money claims against Intel and Mike Wentling, asserting he did not have a mental illness and that Intel violated his right to procedural due process. He also claimed salary differential for his US assignment. Intel defended the dismissal, citing Dr. Lee's certification of Deoferio's non-curable schizophrenia and the potential prejudice to his and his co-employees' health, supported by Deoferio's past disruptive actions and absences. The Labor Arbiter ruled in favor of Intel, finding the dismissal valid and the twin-notice requirement inapplicable to disease-based terminations. The National Labor Relations Commission (NLRC) affirmed this decision, as did the Court of Appeals (CA) in its February 24, 2012 decision and August 2, 2012 resolution, agreeing that the dismissal was justified and procedural requirements were met. The Petition: Deoferio filed a petition for review on certiorari under Rule 45 of the Rules of Court, arguing that his subsequent employment with other companies contradicted the finding of schizophrenia and that the Labor Code mandates the twin-notice requirement even for dismissals due to disease. The respondents contended that the petition raised factual issues beyond the scope of certiorari and that Deoferio's claims were either prescribed or unsupported by agreement. They also argued that his subsequent employment was irrelevant to the validity of his dismissal. The Supreme Court partially granted the petition, affirming the CA's decision but ordering Intel to pay Deoferio P30,000.00 in nominal damages for the violation of his right to procedural due process, while denying the petition with respect to Mike Wentling.
Issue(s)
Whether Deoferio was suffering from schizophrenia and whether his continued employment was prejudicial to his health, as well as to the health of his co-employees. Whether the twin-notice requirement in dismissals applies to terminations due to disease. Whether Deoferio is entitled to nominal damages for violation of his right to statutory procedural due process. Whether the respondents are solidarily liable to Deoferio for nominal damages. Whether Deoferio is entitled to salary differential, backwages, separation pay, moral and exemplary damages, as well as attorney's fees.
Ruling
The Supreme Court partially granted the petition. It affirmed the CA's decision regarding the validity of the dismissal based on authorized cause but ordered Intel to pay Deoferio nominal damages in the amount of ₱30,000.00 for violation of his right to statutory procedural due process. The petition was totally denied with respect to respondent Mike Wentling.
Ratio Decidendi
On whether Deoferio was suffering from schizophrenia and if his continued employment was prejudicial: The Court agreed with the CA that Dr. Lee's psychiatric report substantially proved Deoferio's schizophrenia, its non-curability within six months, and the prejudice to his mental health and that of his co-employees. This conclusion was further substantiated by Deoferio's unusual and bizarre acts at work, such as emailing a cryptic message and disarranging his co-employees' desks, and his numerous absences due to his condition. The Court reiterated that the phrase "prejudicial to his health as well as to the health of his co-employees" under Article 284 of the Labor Code is liberally construed to include non-contagious diseases, citing previous cases involving stroke, heart attack, and eye cataract. The certification from a competent public health authority is considered substantive evidence to prove the disease, its non-curability, and the prejudice it causes. On whether the twin-notice requirement applies to terminations due to disease: The Court ruled that the twin-notice requirement applies to terminations due to disease, reversing the NLRC's and CA's contrary findings. The Court emphasized that Section 2, Rule 1, Book VI of the Implementing Rules and Regulations (IRR) of the Labor Code mandates procedural due process in all dismissals. Citing Sy v. Court of Appeals and Manly Express, Inc. v. Payong, Jr., the Court pronounced that employers must furnish two written notices: one to apprise the employee of the ground for dismissal and another informing of the dismissal after giving the employee an opportunity to be heard. The Court found the NLRC's ruling that the twin-notice requirement does not apply to Article 284 as a jurisdictional error, wholly unsupported by law and jurisprudence. On whether Deoferio is entitled to nominal damages for violation of his right to statutory procedural due process: The Court awarded Deoferio ₱30,000.00 as nominal damages for the violation of his right to statutory procedural due process. While the dismissal was for an authorized cause, Intel failed to comply with the twin-notice requirement. The Court considered Intel's faithful compliance with Article 284 and its IRR, the valid offset of Deoferio's separation pay by his car loan, Intel's financing of his medical expenses for over four years, and the liberal granting of leaves of absence. These factors justified the award of ₱30,000.00, which is lower than the ₱50,000.00 typically awarded for dismissals due to authorized causes where notice requirements are completely ignored. On whether Wentling is personally liable: The Court held that Mike Wentling is not personally liable for the nominal damages. As a corporate officer, he cannot be held liable for acts done in his official capacity, as the corporation has a personality separate and distinct from its officers. There was no ground for piercing the veil of corporate fiction as Wentling acted in good faith and relied on the medical report. On entitlement to salary differential, backwages, separation pay, moral and exemplary damages, and attorney's fees: The Court denied these claims. The claim for salary differential was barred by prescription under Article 291 of the Labor Code, as more than four years had elapsed from the pre-termination of his US assignment. The claims for backwages, separation pay, moral and exemplary damages, and attorney's fees were denied because the dismissal was for an authorized cause and the respondents acted in good faith, despite the procedural defect.
Main Doctrine
While termination due to disease is an authorized cause under Article 284 of the Labor Code, employers must still comply with the twin-notice requirement, and failure to do so warrants nominal damages. A certification from a competent public health authority is crucial to establish the disease's non-curability and prejudice to health.